Philips to private-label Demant hearing aids

Demant, Philips

William Demant (CPH:WDH) said this week that it inked a deal to market its line of hearing aid devices under Royal Philips (NYSE:PHG) brand.

Denmark-based Demant said that Amsterdam-based Philips will offer a complete range of hearing aids, accessories and applications under the Philips HearLink brand

“Based on a shared vision of improving the lives of people through innovative healthcare this new cooperation will not only change the way we see hearing healthcare, but also widen the definition of hearing healthcare, supporting healthier lifestyles and active aging. Combining Demant’s world-leading hearing aid technology with Philips’ global brand presence in healthcare, the cooperation will enrich the hearing healthcare experience,” Philips brand licensing senior director Spencer Ramsey said in a prepared statement.

The companies said that the HearLink devices can be connected to other devices, including smartphones and televisions, and that the products are available now.

“The Philips hearing aids will provide users with an innovative, future-proof hearing solution. We live in an age where user engagement and digital services are shaping the future of healthcare technology. More and more people are conscious of taking control of their own personal healthcare and are using electronic devices to do so. In this light, Philips hearing solutions offers new and exciting premium solutions alongside Philips’ healthcare ecosytem, which will attract interest and generate significant benefits to users, ultimately supporting our valued customer base of hearing care professionals. With this partnership, we take connected hearing healthcare to the next level and offer new and exciting solutions within integrated healthcare services to the benefit of both professionals and people suffering from a hearing loss. Health, caring and innovation are cornerstones in the vision of both Demant and Philips, which makes the partnership a great match for the future. Furthermore, it will strengthen and add value to both companies’ ambition to improve people’s lives,” Demant prez & CEO Søren Nielsen said in a press release.

Earlier this month, Philips won a $450 million contract to supply the U.S. Department of Defense with patient monitoring systems, accessories and training.

Semtech, Sonova ink hearing aid development deal

Sonova

Sonova Holding AG (SIX:SOON) and semiconductor maker Semtech said today they jointly developed a new advanced radio system intended for use in Sonova’s hearing aids.

The new technology, an ultra-small integrated circuit, will serve as the main component in a new generation of hearing aids and enable support for multiple radio protocols in the 2.4GHz band, the companies said.

“This chip allows Sonova to move in a new direction with our hearing aids. The breakthrough radio technology and power management are the game changers for hearing aids. It allows them to support a number of applications that have previously not been possible in a hearing aid, all at low power consumption and low supply voltage. Possible applications span from connectivity to any Bluetooth enabled audio device (e.g. a smartphone or television) to full duplex audio streaming between hearing aids and connectivity to wireless microphones,” Sonova wireless R&D director Marc Secall said in a prepared statement.

The device is also intended to operate on low power, Semtech said.

“Semtech continues to innovate and create flexible, reliable solutions for challenging applications associated with the best radio frequency connectivity at the lowest power and 0.8V supply voltage. Sonova has long been a leader for hearing devices. By implementing Semtech’s technology and enabling access to the cloud, we believe that these devices will enrich the IoT-connected solutions which Semtech is serving with LoRa Technology,” Semtech wireless and sensing products group R&D VP Jean-Paul Bardyn said in a press release.

Last November, Sonova said that it inked a deal to license Ceva’s RivieraWaves Bluetooth intellectual property for use in its Sword 3.0 wireless hearing aid chip, Ceva said today.

The post Semtech, Sonova ink hearing aid development deal appeared first on MassDevice.

Intuitive Surgical wins another indication for da Vinci SP

Intuitive SurgicalIntuitive Surgical (NSDQ:ISRG) said today that it won another indication for the FDA for its da Vinci SP robot-assisted surgery device.

Initially cleared in April 2014 for urological procedures, in June 2018 the federal safety watchdog added a clearance for procedures requiring very narrow access from a single small incision. Today the Sunnyvale, Calif.-based company said the FDA added single-port radical tonsillectomy and tongue base resection procedures to the mix.

“Today’s FDA clearance means surgeons can utilize da Vinci SP robotic-assisted surgery to conduct radical tonsillectomy and tongue base resection transorally,” CEO Gary Guthart said in prepared remarks. “Our single-port innovation is part of our commitment to helping surgeons and their teams improve patient outcomes, decrease variability in surgery, and improve the patient and surgical team experience.

“Intuitive’s da Vinci SP complements our other systems by enabling surgeons to access narrow workspaces while maintaining high quality vision, precision, and control that surgeons have come to trust from da Vinci systems,” Guthart said.

The post Intuitive Surgical wins another indication for da Vinci SP appeared first on MassDevice.

Audion touts Ph1 results for hearing loss drug

Audion Therapeutics logoAudion Therapeutics touted positive results yesterday from a Phase I trial of the company’s hearing loss drug.

In 15 people with mild to moderate sensorineural hearing loss, Audion tested the safety and tolerability of its LY3056480 mediated Notch inhibitor. The drug is designed to regenerate the inner ear sensory hair cells that are lost over time.

Get the full story at our sister site, Drug Delivery Business News.

The post Audion touts Ph1 results for hearing loss drug appeared first on MassDevice.

These headphones can clean your ears

Startup SafKan developed its ear-cleaning headphones with help from a ProtoLabs grant. (Image courtesy of SafKan)

Tucson-based startup SafKan has developed a pair of headphones that can professionally clean a patient’s ear in just 35 seconds.

Winner of Protolabs’ Cool Idea! Award, SafKan is working on meeting customization requirements during the pivotal beta program stage for its device, OtoSet. The headphones have disposable silicone nozzles that spray a warm saline solution against the walls of the ear canal while sucking the solution and wax back into the nozzles and disposable outflow containers, avoiding messy spills, the company said.

Get the full story on our sister site, Medical Design & Outsourcing.

The post These headphones can clean your ears appeared first on MassDevice.

Decibel, Cocoon tackle drug delivery to the inner ear using silk

Cocoon Biotech, Decibel TherapeuticsDecibel Therapeutics and Cocoon Biotech announced yesterday that the two companies plan to work together to research drug formulations optimized for transtympanic delivery to the ear.

The collaboration will make use of Cocoon’s silk fibroin platform and Decibel will have an option to exclusively license the technology on a program-by-program basis.

Get the full story at our sister site, Drug Delivery Business News.

The post Decibel, Cocoon tackle drug delivery to the inner ear using silk appeared first on MassDevice.

Tivic Health’s OTC sinus pain device wins FDA nod

 

(Image courtesy of Tivic Health)

Tivic Health Systems said that its ClearUP device for allergy-induced sinus pain has received 510(k) clearance from FDA.

 

ClearUP is an over-the-counter device that provides consumers with a simple, non-invasive and drug-free option to relieve sinus pain caused by various environmental allergies such as dust, mold, pollens and pet dander, according to the San Francisco-based company.

Get the full story on our sister site, Medical Design & Outsourcing.

The post Tivic Health’s OTC sinus pain device wins FDA nod appeared first on MassDevice.

Frequency Therapeutics raises $42m for hearing regeneration drug

Frequency Therapeutics updated logoFrequency Therapeutics said today that it closed a $42 million Series B round to support the clinical development of its hearing regeneration drug, FX-322.

The company is slated to publish top-line data from an ongoing Phase I/II study of FX-322 in the first half of the year.

Get the full story at our sister site, Drug Delivery Business News.

The post Frequency Therapeutics raises $42m for hearing regeneration drug appeared first on MassDevice.

Intersect ENT launches trial of drug-coated sinus balloon

Intersect ENT updated logoIntersect ENT (NSDQ:XENT) said today that it enrolled the first patient in a trial of its Ascend drug-coated sinus balloon.

The Menlo Park, Calif.-based company’s device is designed to deliver mometasone furoate directly to a person’s sinuses at the time of dilation.

Get the full story at our sister site, Drug Delivery Business News.

The post Intersect ENT launches trial of drug-coated sinus balloon appeared first on MassDevice.

Sonova licenses Ceva’s RivieraWaves Bluetooth tech for Sword 3.0 hearing aid chip

Sonova

Sonova Holding AG (SIX:SOON) has inked a deal to license Ceva’s RivieraWaves Bluetooth intellectual property for use in its Sword 3.0 wireless hearing aid chip, Ceva said today.

The licensed RivieraWaves Bluetooth IP platform consists of a hardware baseband controller and software protocol stack and will help power the Sword 3.0, which Sonova touts as the world’s first and only hearing aid radio chip that will fully support direct binaural streaming of audio content.

“We are delighted to formally announce our partnership with Sonova, for our RivieraWaves Bluetooth IP. It’s a testament to the quality of our Bluetooth technology for even the most stringent use cases and we look forward to continuing our work together as Bluetooth looks set to become the wireless standard of choice for hearing aids and other smart hearing devices,” CEVA connectivity biz GM Aviv Malinovitch said in a prepared statement.

The Sword 3.0 device is intended to connect to a smartphone for internet access that will allow the devices to be adjusted remotely by their hearing care professional, the companies said.

“Our latest generation Sword chip reinforces our mission to continually introduce new and innovative technologies that greatly improve the user experience of hearing aids. The integration of CEVA’s advanced Bluetooth Dual Mode IP into our wireless chip enables us to bring low power stereo audio streaming and data connectivity to our hearing aids, giving our customers an unparalleled user experience,” Sonova wireless R&D director Marc Secall said in a press release.

In August, Sonova subsidiary Advanced Bionics said that it won FDA approval for its HiRes Ultra 3D cochlear implant.

The post Sonova licenses Ceva’s RivieraWaves Bluetooth tech for Sword 3.0 hearing aid chip appeared first on MassDevice.